This brand name is authorized in Cyprus, Finland, France, Hong Kong SAR China, Ireland, Israel, Japan, Netherlands, South Africa, Spain, Tunisia.
The drug NORLEVO contains one active pharmaceutical ingredient (API):
1
|
UNII
5W7SIA7YZW - LEVONORGESTREL
|
|
The precise mode of action of levonorgestrel as an emergency contraceptive is not known. At the recommended regimen, levonorgestrel is thought to work mainly by preventing ovulation and fertilisation if intercourse has taken place in the preovulatory phase, when the likelihood of fertilisation is the highest. |
|
Below package inserts are available for further reading:
| Document | Type | Information Source | |
|---|---|---|---|
| NORLEVO Tablet | MPI, EU: SmPC | Health Products Regulatory Authority (IE) |
This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:
| ATC Group | Classification | |
|---|---|---|
| G03AC03 | Levonorgestrel | G Genito urinary system and sex hormones → G03 Sex hormones and modulators of the genital system → G03A Hormonal contraceptives for systemic use → G03AC Progestogens |
| G03AD01 | Levonorgestrel | G Genito urinary system and sex hormones → G03 Sex hormones and modulators of the genital system → G03A Hormonal contraceptives for systemic use → G03AD Emergency contraceptives |
This drug has been assigned below unique identifiers within the countries it is being marketed:
| Country | Identification scheme | Identifier(s) |
|---|---|---|
| ES | Centro de información online de medicamentos de la AEMPS | 3400936413726, 67770, BE277356 |
| FI | Lääkealan turvallisuus- ja kehittämiskeskus | 025691 |
| FR | Base de données publique des médicaments | 60812935 |
| HK | Department of Health Drug Office | 55593 |
| IL | מִשְׂרַד הַבְּרִיאוּת | 5265 |
| JP | 医薬品医療機器総合機構 | 254900AF2024 |
| NL | Z-Index G-Standaard, PRK | 78921 |
| TN | Direction de la Pharmacie et du Médicament | 4983011, 4983012 |
| ZA | Health Products Regulatory Authority | 33/21.8.2/0471 |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.